ChemicalBook > CAS DataBase List > Unii-9927mt646m
Unii-9927mt646m
- Product Name
- Unii-9927mt646m
- CAS No.
- 179045-86-4
- Chemical Name
- Unii-9927mt646m
- Synonyms
- Simulect;Bailiximab;SDZ-CHI 621;Unii-9927mt646m;from USAN List 422;Basiliximab (anti-IL-2Ra);Research Grade Basiliximab;Research Grade Basiliximab (DHB95802);Immunoglobulin G 1 (human-mouse monoclonal chi621 heavy chain anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal chi621 light chain, dimer
- CBNumber
- CB12497397
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Unii-9927mt646m Property
- storage temp.
- Store at -20°C
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Safety
- Hazardous Substances Data
- 179045-86-4(Hazardous Substances Data)
More
Less
N-Bromosuccinimide Price
American Custom Chemicals Corporation
- Product number
- ATB0010208
- Product name
- BASILIXIMAB
- Purity
- 98.00%
- Packaging
- 5MG
- Price
- $498.39
- Updated
- 2021/12/16
More
Less
Unii-9927mt646m Chemical Properties,Usage,Production
Uses
Immunosuppressant (monoclonal antibody).
brand name
Simulect (Novartis).
in vivo
Basiliximab (CHI 621) (0.07 mg/rat; i.v.; once) decreases total placental natural killer cells in reduced uterine perfusion pressure (RUPP) rats[2].
| Animal Model: | Timed-pregnant Sprague Dawley (SD) rats, reduced uterine perfusion pressure (RUPP) rat model of placental ischemia[2] |
| Dosage: | 0.07 mg/rat |
| Administration: | IV infusion, once |
| Result: | Decreased total placental natural killer cells. Had no effect to lower MAP or improve pup weight and placental weight. |
Unii-9927mt646m Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Unii-9927mt646m Suppliers
- Tel
- 1-(800)-881-8210
- Fax
- 615-250-9817
- inquiries@lgmpharma.com
- Country
- United States
- ProdList
- 2123
- Advantage
- 70
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
179045-86-4, Unii-9927mt646mRelated Search:
Ranibizumab
Vantictumab
Garadacimab
Envafolimab
Mitumomab
Bermekimab
Perakizumab
Enlimomab
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 κ-chain, dimer
Nerelimomab [usan:inn]